CIK 0001101026 · Non-accelerated filer<br>Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870699977
- Phone
- (248) 452 9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-14 | Maggiore Christopher D. Director | Purchase | +5,200 | $3.53 | $18K | 721,282 |
| 2022-09-14 | Maggiore Christopher D. Director | Purchase | +2,000 | $3.55 | $7K | 723,282 |
| 2022-09-14 | Maggiore Christopher D. Director | Purchase | +5,200 | $3.53 | $18K | 808,305 |
| 2022-09-14 | Maggiore Christopher D. Director | Purchase | +2,000 | $3.55 | $7K | 810,305 |
| 2022-08-29 | Marchiando Keith Director | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +62,000 | 62,000 | ||
| 2022-07-28 | Masterson Nola E Director | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +15,797 | 15,797 | ||
| 2022-07-28 | Maggiore Christopher D. Director | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +15,797 | 15,797 | ||
| 2022-07-28 | Cornell Alison A Director | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +15,797 | 15,797 | ||
| 2022-07-28 | Masterson Nola E Director | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +15,797 | 15,797 | ||
| 2022-07-24 | STROME MARK E 10% owner | Other disposition · Common Stock Purchase Warrant | −3,125 | 0 | ||
| 2022-07-08 | Maggiore Christopher D. Director | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +15,797 | 15,797 | ||
| 2022-02-11 | Maggiore Christopher D. Director | Purchase | +44,965 | $3.87 | $174K | 803,105 |
| 2022-02-10 | Maggiore Christopher D. Director | Purchase | +18,006 | $3.64 | $65K | 758,140 |
| 2022-02-09 | Maggiore Christopher D. Director | Purchase | +28,363 | $3.55 | $101K | 740,134 |
| 2022-01-27 | PAYNE JOHN BERNARD Director | Purchase | +46 | $2.50 | $115 | 9,344 |
| 2022-01-25 | PAYNE JOHN BERNARD Director | Purchase | +9,122 | $2.50 | $23K | 9,298 |
| 2022-01-11 | Maggiore Christopher D. Director | Purchase | +7,560 | $2.64 | $20K | 711,771 |
| 2021-10-21 | DAHL ANDREW A President / CEO | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +376,000 | 376,000 | ||
| 2021-10-21 | Maggiore Christopher D. Director | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +42,000 | 42,000 | ||
| 2021-10-21 | PAYNE JOHN BERNARD Director | Grant or award · Nonstatutory Stock Option to Purchase Common Stock | +192,000 | 192,000 |
Page 6 of 12 · 228 trades